Normalization of tumor vasculature by R-Ras
Normalization of tumor vasculature by R-Ras
批准号:
9283466
负责人:
Masanobu Komatsu
金额:
$13.06万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-10 至 2019-05-31
关键词:
ActinsAddressAnimal ModelAttentionAttenuatedBlood CirculationBlood VesselsCDH13 geneCell Differentiation processCerebral EdemaChronicClinicalCoculture TechniquesCombined Modality TherapyDrug Delivery SystemsEndothelial CellsExtravasationFundingGeneticGenetic ModelsGoalsImpairmentIn VitroInvestigationKDR geneKnockout MiceLinkMalignant NeoplasmsMediatingMethodsMolecularMolecular TargetMonomeric GTP-Binding ProteinsMusNeoplasm MetastasisOxygenPathway interactionsPericytesPermeabilityPhosphorylationPlasmaProcessRadiation therapyRegulationRoleSeriesSignal PathwaySignal TransductionStructureSystemTGF-beta type I receptorTherapeuticTransforming Growth Factor betaTransgenic MiceTumor Cell InvasionTumor ImmunityTumor-Associated ProcessVascular Endothelial Growth FactorsVascularizationbaseblood perfusioncadherin 5cancer cellcell motilitycell typechemotherapeutic agentclinically significantexperimental studyfunctional disabilitygain of functionimprovedin vivoinducible gene expressioninnovationinsightnanomedicineneoplastic cellnotch proteinpublic health relevanceresponsetargeted treatmenttumorvascular abnormality
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Newly formed blood vessels fail to mature into fully functional vessels in tumors due to the chronically angiogenic microenvironment. The functional impairment of these vessels hampers drug delivery, thereby diminishing the efficacy of antitumor therapies. Excessive vessel permeability associated with tumors also allows tumor cell invasion into the circulation facilitating metastatic spreading. Therefore, the ability to conrol vessel maturity in tumors provides a potential therapeutic opportunity. The long-term goal of this study is to understand the molecular basis for vascular maturation. Our recent studies uncovered an essential role of the small GTPase R-Ras in establishment of mature, functional blood vessels in tumors. Thus, R-Ras promotes normalization of the tumor vasculature. Now, the important new objective of this investigation is to determine the molecular pathway for R-Ras-mediated vessel regulation so that new molecular targets may be identified for controlling the tumor vasculature for therapeutic advantage. R-Ras enhances vascular integrity through regulation of VE-cadherin. Our recent studies also show that R-Ras attenuates VEGF signaling in endothelial cells by inhibiting VEGFR2 internalization upon VEGF stimulation. Furthermore, R-Ras not only promotes endothelial cell-pericyte association but also facilitates intercellular signaling between the two cell types via TGF-beta and Jagged1-mediated Notch signaling. These pathways promote endothelial cell quiescence and mural cell differentiation; therefore, they are important for vessel maturation. Based on these observations, we propose a hypothesis that R-Ras orchestrates these pathways to redirect nascent tumor vessel formation from an angiogenic sprouting/branching process to a maturation process. In this proposal, we will investigate the significance and precise roles of the R-Ras pathways during tumor vascularization. In Aim 1, we will identify and characterize the key signaling pathways mediating the R-Ras effects on endothelial cells and pericytes in a series of in vitro experiments using various culture/coculture systems. In Aim 2, we will validate the findings from Aim 1 in various animal models to determine the role of these mechanisms during the establishment of functional tumor vessels. The proposed studies will provide an important insight into the molecular basis for the vascular normalization phenomenon and its implications in tumor malignancy and therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of intratumoral high endothelial venules in tumor immunity
-
批准号:10444131
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2022
-
负责人:Masanobu Komatsu
-
依托单位:
Role of intratumoral high endothelial venules in tumor immunity
-
批准号:10590624
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2022
-
负责人:Masanobu Komatsu
-
依托单位:
Normalization of tumor vasculature by R-Ras
-
批准号:8267707
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
Normalization of tumor vasculature by R-Ras
-
批准号:7655522
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
Targeting Pulmonary Hypertension with R-Ras
-
批准号:7395191
-
项目类别:
-
资助金额:$16.57万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
Normalization of tumor vasculature by R-Ras
-
批准号:7460484
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
Normalization of tumor vasculature by R-Ras
-
批准号:9064698
-
项目类别:
-
资助金额:$43.88万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
Normalization of tumor vasculature by R-Ras
-
批准号:8077263
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
Normalization of tumor vasculature by R-Ras
-
批准号:8761755
-
项目类别:
-
资助金额:$43.88万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
Normalization of tumor vasculature by R-Ras
-
批准号:7843732
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2008
-
负责人:Masanobu Komatsu
-
依托单位:
海外基金